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Abstract
Background: Pulmonary artery stenting without a long vascular sheath has a special signifi-
cance, particularly for children with low body weight. Using only a short sheath often permits
the implantion of a stent of the correct size; moreover, it improves access to peripherally located
stenoses. The aim of this paper is to present the results of a balloon expandable stent implanta-
tion into pulmonary arteries without using a long vascular sheath.
Methods: The subjects were divided into two groups. The first group (28 patients, mean age
3.2 years) comprised patients with a single-ventricle heart after bi-directional Glenn procedure
(Fontan procedure). The second group (22 patients, mean age 8.3 years) consisted of patients
with a two-ventricle heart. Patients were retrospectively analyzed with regard to stenosis size
widening and change in trans-stenotic pressure gradient after stenting.
Results: In our data, no statistically significant differences between the two groups in terms
of the number of complications and incorrect stent position following implantation were noted
(3% and 4%). Good treatment results, with a decrease in trans-stenotic pressure gradient in
the first group of 3.2 mm and in the second group of 13.4 mm of mercury, and a widening of
the stenosis, were obtained in most cases in both groups (97% and 96%). The average change
of the vessel’s diameter was in the first group 4.2 mm and in the second 5.4 mm.
Conclusions: The obtained results suggest that pulmonary artery stenting with a short vascu-
lar sheath has numerous advantages and can be successfully performed in children. In the case
of single-ventricle hearts after a Glenn procedure, it may indeed be the method of choice.
(Cardiol J 2010; 17, 2: 149–156)
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Introduction
Implanting a balloon expandable stent into the
pulmonary artery without using a long vascular
sheath constitutes an interesting alternative to the
traditional method of stenting, in which a long vas-
cular sheath is introduced into a stenosis. This
method permits the use of a smaller-sized introduc-
er sheath, which is of crucial importance in children,
because the sheath’s size can be an obstacle to us-
ing a stent with adequate parameters [1, 2].
On the other hand, veins cannulated by a small-
er introducer sheath have more chance of being
patent after procedure and this would be a valuable
approach during the next catheterization. The vast
majority of the method’s reported disadvantages
concern the lack of control over the stent’s posi-
tion directly before expansion and absence of pro-
tection of the stent on the balloon during passage
to the pulmonary arteries. This means pre-proce-
dure angiography must be carried out. During the
procedure, the patient’s position relative to the
X-ray tube must remain unchanged. Unfortunate-
ly, these methods (aimed at ensuring optimal stent
localization) are difficult to reproduce and to a large
extent rely on the experience of the operator and
the team conducting the procedure. The alternative
to this procedure is to cannulate the opposite vein
and then, through a catheter, control angiography
before stent implantation is possible.
In some clinical situations, stenting without the
use of a long vascular sheath may be selected by
choice. In the case of single-ventricle hearts after
bi-directional Glenn, it is often possible to perform
angiography through a short vascular sheath next
to the balloon catheter [2].
The aim of this paper is to present a one-cen-
ter experience of pulmonary artery stenting in chil-
dren using a short introducer sheath.
Methods
This study is based on a retrospective analy-
sis of 50 consecutive patients with pulmonary ar-
tery stenosis qualified for angioplasty and balloon
expandable stent implantation at our center be-
tween 2003 and 2008. The patients were divided
into two groups depending on co-existing heart
defects, which affected the nature of the procedure
and its course. The first group comprised 28 chil-
dren (girls accounted for 35% of the group, boys
65%) aged three months to seven years (average
age: 3.2 years), with a single-ventricle heart after
a bi-directional Glenn procedure. In this group,
a short vascular sheath was introduced through the
right internal jugular vein. The second group con-
sisted of 22 patients (girls 36%, boys 64%), aged
one month to 20 years (average age: 8.3 years) with
other heart defects (two-ventricle hearts). In this
group, a short vascular sheath was introduced
through a femoral vein and the defects included
tetralogy of Fallot and multilevel peripheral stenos-
es in William’s syndrome.
As for the first group, stenting with a short
sheath is in our department the procedure of choice,
so the group consisted of consecutive patients fol-
lowing bidirectional Glenn (BDG) operation. Most
of this group are children with hypoplastic left heart
syndrome (HLHS). We do not perform primary an-
gioplasty because, in our experience, primary an-
gioplasties in these patients are ineffective and wid-
ened stenoses quickly return. In this group, angio-
graphic control of the stent position was performed
directly before expansion (the short sheath is quite
near to the site of the stenosis).
In the second group, short introducer sheaths
were used in specific cases: in small children with
recurrent, multifocal stenoses of the pulmonary
arteries such as William’s or Allagile syndrome
(three patients in the second group), a short sheath
was preferable because it meant less trauma for
vessels and easy stent delivery into peripherial
parts of the pulmonary atresia. In patients with
a single ventricle with pulmonary valve atresia,
a short sheath was also used to reach the site of the
stenosis in pulmonary arteries though the femoral
vein, tricuspid and aortic valves and Blalock-Tauss-
ing shunt as well as through the femoral artery, aor-
ta and Blalock-Taussing shunt. In all these patients,
pre-dilatation was performed and when angioplas-
ty was ineffective, a decision about stenting was
made. In this group, we did not perform control
angiography before stenting expansion, as it would
require secondary femoral vein cannulation. To set
it in the proper position, we used the method de-
scribed by Pass et al. [1].
All the interventions were performed under
general anesthesia with endotracheal intubation in
the catheter laboratory. Heparin 50–100 U/kg of
body weight was given after vascular access was
obtained. A single-plane Philips Integris CV angio-
graph was employed in the procedures. Average
fluoroscopy time was for Group 1: 18 min (8–42) and
for Group 2: 28 min (15–36). Four hours after com-
pletion of the procedure, 1–2 mg/kg of body weight
low-molecular weight heparin (enoxaparin sodium-
-clexane) was administered subcutaneously and
the patients were then maintained on oral acetyl-
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salicylic acid 2–3 mg/kg of body weight once daily.
The technique of stenting and all procedures re-
mained unchanged during the period of study.
A short vascular sheath was used in both groups:
6 French for 7 mm stent and 7 French for 8 mm
stent diameter (Tables 1, 2).
Patients in both groups were retrospective-
ly analyzed with regard to stenosis size, widen-
ing obtained after stenting, change in the mean
pressure in the stented artery after implantation,
arterial blood saturation,their clinical condition,
and the presence of complications stemming from
the treatment method used. The balloon expand-
able stents were delivered uncovered to the dis-
tal pulmonary circulation using a short vascular
sheath. The position of the stent prior to deploy-
ment was confirmed via comparison with a digi-
tal freeze frame of initial angiograms (method
described by Pass et al. [1]). In the first group,
additional angiography was performed by a short
sheath. For the second group, we did not repeat
angiogram with a second angiographic catheter. In
all control cases, angiography was performed after
stent implantation to confirm its proper position.
Table 1. Characteristics of group 1.
No. Age Weigh Pre-dilatation Post-dilatation Pre- and Type of stent Complications
(months) [kg] stenosis stenosis post-dilatation (size of sheath)
diameter diameter difference
in pressure
gradient
[mm Hg]
1 72 15 3 7.5 3 Genesis 7 × 24 (6 F)
2 20 18.5 3.9 7.5 2 Genesis 7 × 24 (6 F)
3 34 8 3.6 7.4 5 Genesis 7 × 25 (6 F) Severe complication (CNR)
4 20 10.5 5.2 8.5 5 Genesis 8 × 30 (7 F)
5 41 13 4.2 8.5 2 Genesis 8 × 24 (7 F)
6 60 15 3 10* 1 Genesis 8 × 29 (7 F)
7 32 13 4.1 8.1 0 Genesis 7 × 13 (6 F)
8 10 5.6 4 7.3 4 Genesis 8 × 25 (7 F)
9 6 5.5 3.5 6 6 Genesis 6 × 18; Mild complication (CNR)
7 × 24 (6 F)
10 72 17 3.5 7.5 1 Genesis 7 × 24 (6 F)
11 3 4.5 1.5 4.2 2 Coroflex 3.5 × 16 (4 F)
12 7 6 2 7 12 Genesis 7 × 24; Unexpected course (CNR)
CP (9 F) 8 × 22
13 81 19 7.8 14 3 P-308 J & J 14 × 40 (10 F) Severe complication (CR)
14 39 15 4 6 5 Genesis 6 × 25 (6 F) Critical complication (CNR)
15 34 13 3.5 7 2 Genesis 7 × 24 (6 F)
16 34 14 3.5 7 2 Genesis 7 × 24 (6 F)
18 5 5.4 3.5 9.3* 3 Genesis 6 × 15 (6 F)
19 46 15 3.5 7.5 0 Genesis 7 × 24 (6 F)
20 36 11.5 6 10* 2 Genesis 8 × 25 (7 F)
21 66 17 4.5 11 6 Genesis 8 × 29 (7 F)
22 48 19 6 10 2 Cordis 10 × 35 (9 F)
23 35 13 3.5 10* 5 Genesis 8 × 36 (7 F)
24 29 12 4.2 8.5* 4 Genesis 6 × 16 (6 F)
25 48 12 4.75 7 2 Genesis 7 × 24 (6 F)
26 52 14 5.5 8 3 Genesis 8 × 18 (7 F)
27 45 13 2 8.4 4 Genesis 8 × 18 (7 F)
28 64 15 4.1 8* 1 Genesis 7 × 24 (6 F)
*patients with second angioplasty and additional stent dilatation; CNR — complications not related to performed procedures with short vascular
sheath; CR — complications related to performed procedures with short vascular sheath
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The observed complications were classified
into three main groups with regard to their severi-
ty: critical complications (procedures ending in the
patient’s death or in the need for resuscitation),
severe complications (necessitating simultaneous
additional emergency or surgical procedures), and
mild complications (resulting in the postponement
of the procedure or in a non-optimal result of the
stent implantation). In each case, efforts were made
to establish and account for the mechanism of ori-
gin and the cause of the complications. Statistical
analyses of the results were performed using Sta-
tistica 8.0 software.
Results
In the first group (single-ventricle hearts),
80% of the stenoses were located in the left pul-
monary artery: anatomically, at the primary bifur-
cation of the pulmonary arteries. The disparity
results from the quantitative dominance of pa-
tients with HLHS, in whose case stenoses may
stem, among others, from changes to the geome-
try of the pulmonary arteries following the first
stage of the Norwood procedure, which consti-
tutes a predisposition to their kinking or stenos-
is and results (in most cases) in angioplasty prov-
ing ineffective [3].
Stenoses subject to intervention (average
stenosis size: 4 mm; 1.5–5.5 mm) were dilated with
the use of a short introducer sheath inserted through
the right internal jugular vein. Successful widening
was obtained in 27 patients (97%), with an average
change of 4.2 mm (p < 0.01; Shapiro-Wilk test, de-
pendent t-test); the average decrease obtained in the
trans-stenotic pressure gradient in the pulmonary
artery was 3.2 mm of mercury (p < 0.01).
Within this group, complications occurred in four
procedures (14%); only two were however related to
the short sheath stent implantation procedure (7%).
In one case, the patient with HLHS developed
bradycardia and cardiac arrest during a 6 × 25 mm
Table 2. Characteristics of group 2.
No. Age Weigh Pre-dilatation Post-dilatation Pre- and Type of stent Complications
(months) [kg] stenosis stenosis post-dilatation (size of sheath)
diameter diameter difference
in pressure
gradient
[mm Hg]
1 44 14.5 2.5 7.2 28 Cordis 6 × 30 (6 F)
2 72 28 3 11* 16 Genesis 8 × 29 (7 F) Severe complication (CNR)
3 192 55 5.6 15.5 12 Genesis 8 × 39 (7 F)
4 2 4.5 2.3 10 2 Coroflex 3.5 × 16 (4 F)
5 1 3.3 1 4.2 11 Coroflex 3.5 × 16 (4 F)
6 45 14 4.2 6.5 49 Genesis 7 × 25 (6 F) Mild complication (CNR)
7 15 8.8 2.7 8 18 Genesis 6 × 23 (6 F) Critical complication (CNR)
8 72 19 2.5 8 7 Genesis 6 × 24 (6 F)
9 240 64 6.3 12* 4 Genesis 7 × 24 (6 F)
10 204 57 6 14 10 Genesis 14 × 40 (9 F)
11 156 44 4.5 10 18 J & J 8–12/30 mm (9 F)
12 79 21 3 7 3 Genesis 7 × 22 (6 F)
13 72 19 1.5 8 5 Genesis 6 × 22; 7 × 24 (6 F) Mild complication (CR)
14 42 12 6 7 14 Genesis 7 × 24 (6 F)
15 240 52 6 15.2** 34 Genesis 8 × 29 (7 F)
16 120 34 5.2 12 2 Palmaz P-308 (7 F)
18 156 49 2.1 7.4 11 Genesis 7 × 23 (6 F)
19 120 32 3.5 9.3 16 Genesis 8 × 26 (7 F)
20 144 43 5 9.2 13 Genesis 9 × 35 (8 F)
21 60 18 0 4 8 2 × Cordis 4 × 23 (4 F)
22 11 6.8 4 5.6 2 Genesis 8 × 29 (7 F)
 *patients with second angioplasty and additional stent dilatation; **stent was manually crimped on OPTA high pressure balloon 16 × 40;
CNR — complications not related to performed procedures with short vascular sheath; CR — complications related to performed procedures with
short vascular sheath
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Genesis stent implantation into a tight stenosis lo-
cated at the left pulmonary artery bifurcation. Fol-
lowing 30-minute full resuscitation, hemodynami-
cally efficient heart function was restored. On day
two after the procedure, aortography and coronar-
ography were performed. Theserevealed reshaping
of the primary ascending aorta’s border because of
the stent’s proximal end. Further post-dilatation of
the stent’s proximal section, planned earlier, was
considered inadvisable and thus was not performed,
despite the existing disproportion between the stent
and the right pulmonary artery (Table 1, No. 14).
Regarding severe complications, there was one
case when during introduction of a manually
crimped Palmaz P-308 stent on a 12 mm balloon
through a narrowed left pulmonary artery, the stent
slipped off the balloon and migrated into the left
lower lobe pulmonary artery. The unexpanded stent
was removed over a smaller 6 mm balloon up to the
right internal jugular vein, from where it was re-
moved after surgical exposure. Three months lat-
er, the intervention was repeated with successful
implantation of a P-308 stent into the left pulmo-
nary artery (Table 1, No. 13).
In one child, an over-lengthened stent was
implanted in the long-segment hypoplasia of the left
pulmonary artery. Its proximal end protruded into
the Glenn anastomosis. One week later, at the time
of completion of the Fontan operation, the stent was
trimmed surgically (Table 1, No. 3).
One stent was implanted too proximally and as
a result, did not cover the whole stenosis of the left
pulmonary artery; angiography repeated three
months later revealed further development of the
stenosis directly behind the stent. A second stent
was implanted in an overlapping fashion, with the
proximal segment of the second stent over the first
one. The stent covered the stenosis completely
with a good result (Table 1, No. 9).
In this group, we had also one unexpected
course which involved a child catheterized be-
cause of a severe condition after a bi-directional
Glenn procedure: high systemic venous pressure
and low oxygen saturation. During this procedure,
we implanted a Palmaz-Genesis stent 7 × 24 mm
into the critical stenosis of the left pulmonary
artery. After the heart catheterization, the patient
was in good condition; one week later, however,
during preparation for extubation, the infant sud-
denly developed bradycardia and subsequent
asystole. A resuscitation procedure with heart
massage was successful. But afterwards, an X-ray
examination revealed that the stent was broken
into two parts and dislocated. Another cardiac
catheterization was performed and the distal end
of the broken stent was gently translocated us-
ing a low-pressure TYSHAK balloon, which was
pulled back, together with the distal part of the
stent. Afterwards, we implanted a CP-stent 8 ×
× 22 mm (something typically used in the treat-
ment of aortic coarctation) into the two separat-
ed parts of the broken stent (Fig. 1). The CP-stent
was manually crimped onto an 8 mm high-pres-
sure balloon. We stabilized and connected the
proximal and distal parts of the broken Genesis
stent (Table 1, No. 12) [4, 5].
In the second group (two-ventricle hearts), the
stenoses were not observed more frequently in any
Figure 1. A. Fluoroscopic view: CP-stent implanted into the broken Genesis stent. Treatment of complication not
related to performed procedures with short vascular sheath; B. Angiography: contrast medium flow.
A B
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of the pulmonary vessels (LPA 40%; RPA 44%).
The stenoses (on average 3.66 mm) were dilated
with very good results: in 21 patients (96%), a sta-
tistically significant widening of the vessel’s diam-
eter was obtained, on average by 5.4 mm (p < 0.01;
Shapiro-Wilk test, dependent t-test), with a de-
crease in mean gradient at the stenosis by 13.4 mm
of mercury (p < 0.01). Within the group discussed,
one critical, one severe, and two mild complications
were observed. In total, complications amounted to
18% of cases. Only one was directly connected to
our method of stent implantation, and no complica-
tions related to tricuspid or pulmonary valve dam-
ages were observed.
There was a critical complication in the case
of a child with William’s syndrome and extreme
hypoplasia of the pulmonary arteries. The patient’s
condition deteriorated rapidly after stent implanta-
tion into the right pulmonary artery, and a signifi-
cant increase in blood flow through the right lung
was observed. The patient developed pulmonary
oedema; mechanical ventilation was needed, fol-
lowed by the patient’s one-week stay in the inten-
sive care unit (ICU). After this period, the patient’s
condition improved and no further complications
were observed (Fig. 2; Table 2, No. 7).
Another child with tetralogy of Fallot (a severe
cardiac complication) after palliative surgical treat-
ment underwent catheterization due to a tight left
pulmonary artery stenosis. A stent covering the
proximal stenosis was then implanted. The stent
broke during post-dilatation. A high-pressure bal-
loon was used in order to adjust the stent’s edges
to the diameter of the pulmonary artery behind the
stenosis. It was removed surgically while complete
repair of the defect was conducted (Table 2, No. 2).
In one patient with multi-level stenosis of the
pulmonary arteries, after an implantation on a high-
-pressure balloon, a mild complication was observed
in the form of minor bleeding into the bronchial lu-
men and the presence of blood in the intubation
tube. Mechanical ventilation was continued and the
patient was monitored in the ICU. Heparin was not
administered. On day two after the procedure, the
patient was awakened from the anaesthesia and
extubated without any further complications
(Table 2, No. 6).
In one case, the implanted stent did not cover
a multilevel stenosis (Fig. 3A). It was necessary to
implant another stent in an overlapping fashion
(Fig. 3B; Table 2, No. 13).
No statistically significant differences were
observed between the two groups as to the num-
ber of complications or the frequency of improper
stent placement, with the stenosis outside the ex-
panded stent (3% and 4% respectively, Fisher’s
exact test).
Discussion
Nowadays, the use of metallic stents for the
treatment of pulmonary arterial stenosis (first de-
scribed in 1989) is a well-known treatment. Apart
from discrete stenoses, in which balloon angioplasty
may have some success, stents can also be used for
treating hypoplastic pulmonary arteries in which
balloon angioplasty has been shown to be ineffec-
tive. Stents can be used to treat these lesions when
Figure 2. Angiographic view. Patient with William’s syndrome and pulmonary artery hypoplasia with stent in the
right pulmonary artery before (A) and after (B) stent implantation to the left pulmonary artery.
A B
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they are noted before or after the staged surgical
treatment [6–8].
Stenting of branch pulmonary arteries produc-
es good long-term results. But if used on infants,
stents need to be redilated to keep pace with the
patient’s growth. It has been shown that implanted
stents are covered by endothelium within about six
months and can be redilated several times during
growth, thus enabling the adaptation of diameter of
the pulmonary arteries during the growth of the
patient to adulthood. Fogelman has shown that the
Palmaz stents can be redilated safely up to a diam-
eter of 18 mm, which is usually an acceptable dia-
meter in adults [6, 9–11].
Due to its advantages, stent implantation us-
ing a short vascular sheath is used at our centre in
the treatment of children to bring positive results.
The use of a short vascular sheath increases the
possibility of implanting stents of suitable size pa-
rameters: for introducing a long sheath, cannulation
with two-size larger short sheath is required. Al-
ternative for this procedure is direct vessel canu-
lation with a long sheath. Both methods are more
traumatic for vessels, especially in infants. Some-
times, when a stent has to be implanted through the
femoral artery (pulmonary atresia, patent Blalock-
-Taussig shunt) in a young patient, using a long
sheath is simply impossible because of its required
size. Intracardiac manipulation of a long introducer
sheath, especially passing through tricuspid and pul-
monary valves and right ventricle, may cause car-
diac arrhythmia, because of the low agility of a long
sheath reaching pulmonary stenosis in some cas-
es, especially with multilevel stenosis and high right
ventricular pressure. Moreover, a short sheath does
not reduce agility, and thus facilitates access to ar-
eas anatomically difficult to reach [1, 2].
The method’s drawbacks concern the lack of
control over the stent’s position before implanta-
tion. This, to a large extent, depends on the expe-
rience of the center and the operator. The proba-
bility of a stent being in the wrong position may be
reduced by employing proper procedures facilitat-
ing control over the stent’s position in the vessel
(such as pre-implantation angiography) and also by
ensuring that the patient’s position relative to the
X-ray tube after angiography remains unchanged.
It is possibile to control stent position before ex-
pansion via a second venous approach and angiog-
raphy. However, children with a stent in pulmonary
arteries require several catheterizations to control
patency of pulmonary vessels and to widen the stent
to follow the child’s growth. For this reason, we try
to avoid unnecessary cannulation to keep second
vein patent for future, when the cannulated one
becomes unpatent. In the authors’ opinion, two
veins cannulation for stenting significantly reduc-
es the advantages of a short sheath and should be
reserved for difficult cases when other methods are
impossible to apply.
Our data showed no substantial differences in
the frequency of improper stent placement between
the two groups, although in one of them (single-
-ventricle hearts after bi-directional Glenn proce-
dure) the stent’s position before implantation was
controlled, while in the two-ventricle hearts group
it was not. Understandably, control over the stent’s
position through a short vascular sheath in the case
Figure 3. A. Angiographic view. Stent implanted into right pulmonary artery did not cover the whole stenotic
fragment; B. The same patient after second stent implantation.
A B
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of children after bi-directional Glenn procedure is
attainable only if there is no additional pulmonary
supply through a Blalock-Taussig shunt. Similarly
in both groups, the degree of widening obtained was
satisfactory in all cases with properly placed stents.
Using a short sheath may also induce compli-
cations, as the stent may slip off the balloon while
it is moved in the vessel without a cover. In our
study, we encountered one case of this type in
which the stent was manually crimped onto the
balloon. Today, as most implanted Palmaz-Genesis
stents are crimped onto the balloon in the produc-
tion process, such complications are rare.
Conclusions
Using only a short vascular sheath for balloon
expandable stent implantation into pulmonary ar-
teries is a method which brings with it numerous
advantages and can be safely used in children so
long as the proper procedures are followed. The
operator’s and the team’s own experience are rele-
vant factors in its success.
In the case of single-ventricle hearts after bi-
directional Glenn procedure, and if stenting is per-
formed using the jugular approach, a short sheath
may be preferred, as it permits the performance of
angiography directly from the sheath and allows
control over the stent’s position directly before
expansion, provided that there is no additional pul-
monary blood supply.
In two-ventricle hearts, using a short sheath
to implant a stentmay be an option in small children,
with systemic pressure in right ventricle or pulmo-
nary valve atresia. Another group of patients who
can benefit from this procedure are those with
multilevel or recurrent pulmonary stenoses, which
require several catheterizations to provide pulmo-
nary blood flow and control patency of pulmonary
arteries. In complicated cases, when it is impossi-
ble to reach, or confirm the correct position of, the
stent, control angiography should be performed via
a second catheterization, set up through the oppo-
site femoral vein cannulation.
Our data shows that pulmonary artery stent-
ing without a long introducer sheath can be per-
formed safely with good results and low levels of
complications. Most of the described complications
occurred due to pulmonary stenosis anatomy and
were not related to the technical method of stent
implantation.
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